WNX.LSE Wellnex Life Limited
- Market cap
- GBX 3.29M
- P/E
- -
- P/B
- 0.84x
- ROE
- -61.0%
- Dividend yield
- -
- Fundamental score
- -
Ratios use the latest price and the fiscal year ending Jun 2026.
Is WNX.LSE undervalued?
Graham numberThe Graham number of Wellnex Life Limited cannot be estimated reliably (it needs positive earnings and book value).
Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?
Wellnex Life Limited fundamental analysis
No fundamental analysis for Wellnex Life Limited yet.
Wellnex Life Limited stock price
Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.
About Wellnex Life Limited
Wellnex Life Limited, together with its subsidiaries, develops, markets, and sells health and wellness products in Australia and New Zealand. It offers topical anti-inflammatory creams, sprays, and roll-ons for the relief of joint and muscle pain under the Pain Away brand; caffeine energy liquid capsules and multivitamins under the Wakey Wakey brand; sleep aid products under the Nighty Night brand; teeth whitening solutions under the Mr. Bright brand; pain relief capsules un…
Full company profileWellnex Life Limited financial statements
Wellnex Life Limited annual financial statements (AUD; K = thousand, M = million, B = billion, T = trillion)
| Item | 2021 | 2022 | 2023 | 2024 | 2026 |
|---|---|---|---|---|---|
| Income Statement | |||||
| Revenue | 1.20M | 18.6M | 27.9M | 16.9M | 24.8M |
| Gross Profit | -165K | 4.50M | 4.74M | 5.07M | 7.49M |
| Operating Income | -9.29M | -5.90M | -7.11M | -6.45M | -2.11M |
| EBITDA | - | -6.35M | -11.9M | -11.6M | -1.39M |
| Net Income | -25.0M | -7.45M | -13.8M | -14.7M | -4.55M |
| EPS | -3.72 | -0.84 | -1.14 | -0.52 | -0.06 |
| Balance Sheet | |||||
| Total Assets | 10.4M | 19.6M | 15.0M | 30.6M | 23.8M |
| Total Liabilities | 10.7M | 15.3M | 14.4M | 27.4M | 16.3M |
| Shareholders' Equity | -249K | 4.36M | 594K | 7.18M | 7.45M |
| Cash & Short-term Investments | 7.78M | 3.18M | 322K | 903K | 862K |
| Cash Flow | |||||
| Capital Expenditure | 791K | 42.0K | 0.00 | 0.00 | 0.00 |
| Free Cash Flow | -5.24M | -8.65M | -6.19M | -6.87M | -2.56M |
| Ratios | |||||
| ROE | - | -170.9% | -2,331.0% | -205.2% | -61.0% |
| ROA | -239.5% | -38.0% | -92.1% | -48.2% | -19.1% |
| Net Profit Margin | -2,089.1% | -40.0% | -49.7% | -87.0% | -18.3% |
What these items mean
- Revenue
- Total sales of goods and services in the period.
- Gross Profit
- Revenue minus the direct cost of producing what was sold.
- Operating Income
- Profit from the core business after operating expenses.
- EBITDA
- Earnings before interest, taxes, depreciation and amortization.
- Net Income
- Profit left for shareholders after all expenses, interest and taxes.
- EPS
- Net income divided by shares outstanding.
- Total Assets
- Everything the company owns.
- Total Liabilities
- Everything the company owes.
- Shareholders' Equity
- Assets minus liabilities: the book value that belongs to shareholders.
- Cash & Short-term Investments
- Cash and investments that can be turned into cash quickly.
- Capital Expenditure
- Cash spent on property, plant and equipment.
- Free Cash Flow
- Operating cash flow minus capital expenditure: cash left for dividends, buybacks or debt repayment.
- ROE
- Return on equity: net income divided by shareholders' equity.
- ROA
- Return on assets: net income divided by total assets.
- Net Profit Margin
- Net income as a share of revenue.
Wellnex Life Limited dividends
Wellnex Life Limited has not paid dividends in the last 5 fiscal years.
Who owns Wellnex Life Limited
- Insiders 15.96%
- Institutions 7.55%
- Public & others 76.49%
- Shares outstanding 73.0M
- Free float 45.5M
Wellnex Life Limited company profile
- Company name
- Wellnex Life Limited
- Ticker
- WNX.LSE
- ISIN
- AU0000162281
- Exchange
- London Exchange
- Sector
- Consumer Defensive
- Industry
- Packaged Foods
- Fiscal year end
- June
- Address
- Port Park - Building 2, Port Melbourne, VIC, Australia, 3207
- Phone
- 61 3 8399 9419
- Website
- wellnexlife.com.au
About Wellnex Life Limited
Wellnex Life Limited, together with its subsidiaries, develops, markets, and sells health and wellness products in Australia and New Zealand. It offers topical anti-inflammatory creams, sprays, and roll-ons for the relief of joint and muscle pain under the Pain Away brand; caffeine energy liquid capsules and multivitamins under the Wakey Wakey brand; sleep aid products under the Nighty Night brand; teeth whitening solutions under the Mr. Bright brand; pain relief capsules under the Wagner Liquigesics brand; medicinal cannabis under the Wellness Life brand; and over-the-counter medicines under the Pharmacy Own brand. The company is also involved in the holding of intellectual properties and trademarks of its products; brand and pharma solution businesses; and investment activities, as well as sales and distribution activities. It exports its products to the United Kingdom and the United Arab Emirates. The company was formerly known as Wattle Health Australia Limited and changed its name to Wellnex Life Limited in June 2021. Wellnex Life Limited was incorporated in 2011 and is headquartered in Port Melbourne, Australia.
Wellnex Life Limited management
4- Mr. Eric Jiang B.Com(Hons), BAExecutive Chair
- Mr. Zheng LiCompany Secretary
- Mr. Giuseppe Rinarelli BACC, C.A.Chief Financial Officer
- Nick KroghSales & Marketing Manager